Clinical responses to undiluted and diluted smallpox vaccine.
about
Environmental health research in the post-genome era: new fields, new challenges, and new opportunitiesVaccines for preventing smallpoxSmallpox vaccine: the good, the bad, and the ugly.Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968Cytokine production associated with smallpox vaccine responsesThe ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsDevelopment of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infectionDemographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteersBiological weapons preparedness: the role of physicians.Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists.Emergency response vaccines: lessons learned in response to communicable diseases.The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.The poxvirus A35 protein is an immunoregulatorA randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.The immunology of smallpox vaccines.Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccineHuman antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication studyA quantitative rabbit model of vaccinia keratitis.Atlantic storm.Acute reactogenicity after intramuscular immunization with recombinant vesicular stomatitis virus is linked to production of IL-1βImpact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.Validity of self-assessment of skin reaction after smallpox vaccination.Vaccines for Category A bioterrorism diseases.Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complicationImproved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees.Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsSmallpox: clinical features, prevention, and management.Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.Progress in DNA-based heterologous prime-boost immunization strategies for malaria.Smallpox: what the dermatologist should know.DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.Smallpox antiviral drug development: satisfying the animal efficacy rule.
P2860
Q23914178-10299D91-F0BD-437A-B033-DA87BD77EE70Q24244234-30858708-4FD8-43DE-B405-E393CFBBABC1Q24520563-1698FF53-7EE5-4E69-963F-34116882FEC5Q24656098-218AE3F6-7D3E-4427-8EFA-520D1320A3E8Q24799168-3E0DEF27-5D7A-44A4-B029-5AEE01FD7F87Q26823501-09F889FB-829C-4E2A-BE04-25F9032039E5Q27002660-9D0A0139-43CD-400F-B67B-B8B65958060BQ27321985-F7E8EA81-31C2-455D-BC0C-6EE7E7CB091FQ30228332-D3FEFE5A-1516-4BEF-9567-1572CF009646Q30233407-770294F1-B92D-4845-B5FE-F86B851EF7E5Q30233435-F91A5199-DF68-4005-9ADC-014B98B255C1Q30336126-FCE875C7-FC44-451C-AB1F-12F5C4B31593Q30378554-6F4801D7-740F-49FF-9E4F-353379EF992CQ33558734-0A384787-4ACD-42E0-86E0-69483A020A92Q33624420-709FD042-AC7A-4608-B321-5136082B661BQ33679943-55CF78C6-DE04-412F-9E94-75D2F7CE2A59Q33729509-6D497376-42F8-435E-A3E9-439FA2DFF248Q33743444-1B1D3A8A-DD9F-44A4-9149-B3005D144EC0Q33815680-DB056719-AA5E-465F-ACE4-CEA8B8D051EFQ33892570-5DAAC0B9-62A9-4A29-818B-919B8D50D2A1Q33945612-79FE3493-D943-4F66-882D-AEF911F2BAB8Q34024252-D75B7BDE-0C02-4C4A-A2A9-8B00446108E8Q34135490-CDE354BB-2D68-4FCC-8B81-50EEF61B7F2AQ34360765-E5FB9FCD-B321-491A-AAE1-5E41815E8EF9Q34441577-6D03FC23-DA79-4D87-8BF6-D7EB938A5A95Q34502253-D851E245-595D-4976-BA15-F865AEC2175BQ34757936-8FCDF561-964E-4217-B5D3-BB412044FB44Q35040844-F8C93DE2-A40B-4A7E-B323-24F52D354756Q35127337-4ACCDB72-29CE-4CFA-AE0C-2B900A35F82CQ35156216-D9C6FEA1-BC69-4A4A-964B-F9EAA264D7E7Q35522651-66300EFF-4E13-4ED7-B59F-BF82CD11B8FAQ35557123-30614156-5AA1-45A1-B1B9-36413E7C1748Q35571248-B8133600-02A8-4E3E-B003-E39425868D1BQ35634159-11CBCC75-1D67-48C1-9AC9-B11172BD42C7Q35644860-DFFD796D-5C17-4B98-BF34-C4CBA976AC14Q35805278-98FEB743-1A2D-4277-BC69-65AE064271EAQ35826388-281F8705-B90E-4007-95DE-CC676E790C3CQ35834156-6D14C4CA-4026-41E7-AACB-48E826E65E8DQ36129034-693418EE-9AE6-43C6-9720-2ACD94862564Q36441506-D47A3AB7-DBD2-4422-9577-DE8FB4A2F6FD
P2860
Clinical responses to undiluted and diluted smallpox vaccine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Clinical responses to undiluted and diluted smallpox vaccine.
@en
type
label
Clinical responses to undiluted and diluted smallpox vaccine.
@en
prefLabel
Clinical responses to undiluted and diluted smallpox vaccine.
@en
P2093
P356
P1476
Clinical responses to undiluted and diluted smallpox vaccine.
@en
P2093
Carol O Tacket
Carrie M Nolan
Frances K Newman
John J Treanor
Mark Wolff
National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group
Robert B Belshe
Robert B Couch
Robert Edelman
Sharon E Frey
P304
P356
10.1056/NEJMOA020534
P407
P577
2002-03-28T00:00:00Z